Drug company lobbyist joins Oxfam's cheap drugs campaignBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7293.1011/a (Published 28 April 2001) Cite this as: BMJ 2001;322:1011
- Roger Dobson
A senior lobbyist in the pharmaceutical industry is leaving his job to help to spearhead the battle for cheaper drugs to be made available in the developing world. David Earnshaw, director of European government affairs for SmithKline Beecham, will next month join Oxfam and lead its campaign on access to medicines.
Oxfam has been at the forefront of the growing confrontation over the costs of drugs to the developing world, especially AIDS and HIV treatment, and Mr Earnshaw is highly critical …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial